Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

119.96
BATS BZX Real-Time Price
As of 9:53am ET
 +0.10 / +0.08%
Today’s Change
45.00
Today|||52-Week Range
147.63
-5.58%
Year-to-Date

Today’s Trading

Previous close119.86
Today’s open120.89
Day’s range119.70 - 121.17
Volume1,999
Average volume (3 months)1,084,412
Market cap$12.0B
Data as of 9:53am ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-13.15%
Earnings growth (this year)-25.43%
Earnings growth (next 5 years)+163.00%
Revenue growth (last year)+90.66%
P/E ratioNM
Price/Sales127.96
Price/Book6.76

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.06+0.11%
SGENSeattle Genetics Inc+0.23+0.43%
TSROTESARO Inc+0.25+0.41%
JAZZJazz Pharmaceuticals...+2.03+1.41%
Data as of 9:52am ET, 02/23/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$1.38
Annual revenue (last year)$89.9M
Annual profit (last year)-$490.9M
Net profit margin-545.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts